Form 4: Cingulate Inc. SVP and CFO Jennifer L. Callahan Acquires Stock Options

Cingulate Inc.'s SVP and CFO, Jennifer L. Callahan, was granted stock options as part of her 2024 bonus.

Summary

• Jennifer L. Callahan, the Senior Vice President and Chief Financial Officer of Cingulate Inc., received stock options as part of her 2024 bonus.
• The stock options grant was for 11,539 shares of common stock.
• The exercise price of the options is $4.76 per share.
• The options were granted on January 17, 2025, and are exercisable from that date until January 17, 2035.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management and shareholder interests. There are no indications of negative sentiment.

Positives

• The granting of stock options to a key executive like the CFO can be seen as a positive incentive aligning her interests with those of the shareholders.
• The long ten-year expiry period of the options suggests a long-term commitment from the executive.

Risks

• The exercise of these options could potentially dilute existing shareholders if the options are exercised.

Management Comments

• The option was granted for a portion of Ms. Callahan's 2024 bonus.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology and pharmaceutical industries, aligning management's interests with shareholder value creation.

Comparison to Industry Standards

• Stock option grants are a standard practice for executive compensation across various industries, particularly in growth-oriented sectors like biotechnology.
• The vesting schedule and exercise price are typical for such grants, although specific terms can vary based on company performance and individual agreements.
• Companies like Amgen, Gilead Sciences, and Biogen also use stock options as part of their executive compensation packages.

Stakeholder Impact

• Shareholders may view this as a positive sign of aligning management's interests with the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

stock options, Cingulate Inc., Jennifer L. Callahan, executive compensation, SVP, CFO, equity, bonus